Kintara Therapeutics Inc

NASDAQ:KTRA   1:36:42 PM EDT
15.22
+2.34 (+18.13%)
Earnings Announcements

Kintara Therapeutics Announces Fiscal 2022 Financial Results And Provides Corporate Update

Published: 09/27/2022 13:02 GMT
Kintara Therapeutics Inc (KTRA) - Kintara Therapeutics Announces Fiscal 2022 Financial Results and Provides Corporate Update.
Kintara Therapeutics Inc FY Loss per Share $0.52.
Kintara Therapeutics Inc - at June 30, 2022, Kintara Had Cash and Cash Equivalents of Approximately $11.8 Million.
Kintara Therapeutics Inc - Remain on Track to Start Enrolling Patients in Cmbc Study Around End of September 2022.
Revenue is expected to be $4.91 Million
Adjusted EPS is expected to be -$3.15

Next Quarter Revenue Guidance is expected to be $4.91 Million
Next Quarter EPS Guidance is expected to be -$1.80

More details on our Analysts Page.